MCID: RNL016
MIFTS: 20

Renal Infectious Disease malady

Categories: Nephrological diseases, Genetic diseases

Aliases & Classifications for Renal Infectious Disease

Aliases & Descriptions for Renal Infectious Disease:

Name: Renal Infectious Disease 12 14

Classifications:



External Ids:

Disease Ontology 12 DOID:782
ICD10 33 N15.9
ICD9CM 35 590 590.9
UMLS 69 C0021313

Summaries for Renal Infectious Disease

MalaCards based summary : Renal Infectious Disease is related to von hippel-lindau syndrome and interdigitating dendritic cell sarcoma. An important gene associated with Renal Infectious Disease is NR3C1 (Nuclear Receptor Subfamily 3 Group C Member 1). The drugs Heparin and Norepinephrine have been mentioned in the context of this disorder.

Related Diseases for Renal Infectious Disease

Diseases in the Kidney Disease family:

Acute Kidney Failure Chronic Kidney Failure
Renal Infectious Disease Ren-Related Kidney Disease

Diseases related to Renal Infectious Disease via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 von hippel-lindau syndrome 9.8 CRP NR3C1
2 interdigitating dendritic cell sarcoma 9.8 CRP NR3C1
3 maturity-onset diabetes of the young 6 9.7 CRP NR3C1

Symptoms & Phenotypes for Renal Infectious Disease

Drugs & Therapeutics for Renal Infectious Disease

Drugs for Renal Infectious Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1023)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 772 46507594
2
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-41-2 439260
3
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3 50-02-2 5743
4
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79217-60-0, 59865-13-3 5284373 6435893
5
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 104987-11-3 445643 439492
6
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-28-2 5757 53477783
7
Probenecid Approved Phase 4,Phase 3,Phase 2,Phase 1 57-66-9 4911
8
Ritonavir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 155213-67-5 392622
9
Rifampin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 13292-46-1 5458213 5381226
10
Lopinavir Approved Phase 4,Phase 3,Phase 2,Phase 1 192725-17-0 92727
11
Efavirenz Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 154598-52-4 64139
12
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 51-43-4 5816
13
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 50-18-0, 6055-19-2 2907
14
Midazolam Approved, Illicit Phase 4,Phase 1 59467-70-8 4192
15
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1 7439-89-6 23925
16
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 24280-93-1 446541
17
Tenofovir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 147127-20-6 464205
18
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 128794-94-5 5281078
19
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 73590-58-6 4594
20
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 85721-33-1 2764
21
Morphine Approved, Investigational Phase 4 57-27-2 5288826
22
Lamivudine Approved, Investigational Phase 4,Phase 3,Phase 2 134678-17-4 60825
23
Ganciclovir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 82410-32-0 3454
24
Nitrofurantoin Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 67-20-9 5353830
25
Artesunate Approved Phase 4,Phase 3,Phase 2,Phase 1 88495-63-0 6917864 5464098
26
Azathioprine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 446-86-6 2265
27
Ceftriaxone Approved Phase 4,Phase 3,Phase 2,Early Phase 1 73384-59-5 5479530 5361919
28
Amphotericin B Approved, Investigational Phase 4,Phase 3,Phase 2 1397-89-3 14956 5280965
29
Ribavirin Approved Phase 4,Phase 3,Phase 1,Phase 2 36791-04-5 37542
30
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 185243-69-0
31
rituximab Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 174722-31-7 10201696
32
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-23-7 5754 657311
33
Phenylephrine Approved Phase 4 59-42-7 6041
34
Oxymetazoline Approved Phase 4 1491-59-4 4636
35
Ephedrine Approved Phase 4,Phase 2,Phase 3 299-42-3 9294
36
Bortezomib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
37
Abacavir Approved, Investigational Phase 4,Phase 3,Phase 2 136470-78-5 65140 441300
38
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
39
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 22916-47-8 4189
40
Amikacin Approved, Vet_approved Phase 4,Phase 3,Early Phase 1 37517-28-5 37768
41
Isoniazid Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 54-85-3 3767
42
Pyrazinamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 98-96-4 1046
43
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 83905-01-5 55185 53477736 447043
44
Norgestimate Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 35189-28-7 6540478
45
Fosfomycin Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 23155-02-4 446987
46
Tobramycin Approved, Investigational Phase 4,Phase 3,Early Phase 1 32986-56-4 5496 36294
47
Minocycline Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 10118-90-8 5281021
48
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 81103-11-9 84029
49
Tranexamic Acid Approved Phase 4,Phase 3,Phase 2 1197-18-8 5526
50
Basiliximab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 152923-56-3, 179045-86-4

Interventional clinical trials:

(show top 50) (show all 2405)
id Name Status NCT ID Phase
1 Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients Unknown status NCT01927588 Phase 4
2 Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Unknown status NCT02328963 Phase 4
3 Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection Unknown status NCT00156546 Phase 4
4 Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin Unknown status NCT02443064 Phase 4
5 Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant Unknown status NCT02084446 Phase 4
6 Colistin Pharmacokinetics in Continuous Renal Replacement Therapy Unknown status NCT02081560 Phase 4
7 Hepatitis C in Renal Transplant Recipients Unknown status NCT02108301 Phase 4
8 Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects Unknown status NCT00740064 Phase 4
9 Safe Renal Function In Long Term Heart Transplanted Patients Unknown status NCT00505102 Phase 4
10 Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE) Unknown status NCT01744470 Phase 4
11 A Study Comparing Outcomes of Kidney Transplants in Patients on Steroids Versus Those Who Discontinue Steroids Unknown status NCT00273559 Phase 4
12 Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection Unknown status NCT01594905 Phase 4
13 A Study of Thymoglobulin and Tacrolimus in Liver Transplant Unknown status NCT00564538 Phase 4
14 Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP) Unknown status NCT00761098 Phase 4
15 Effects of Antibiotic Prophylaxis on Recurrent UTI in Children Unknown status NCT02357758 Phase 4
16 PrEP Demonstration Project (PRELUDE Study) Unknown status NCT02206555 Phase 4
17 The Amputation Surgical Site Infection Trial (ASSIT) Unknown status NCT02018094 Phase 4
18 Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients Unknown status NCT02057523 Phase 4
19 Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial Unknown status NCT01799486 Phase 4
20 Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU. Unknown status NCT00172198 Phase 4
21 Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU) Unknown status NCT01319643 Phase 4
22 Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients Unknown status NCT02106962 Phase 4
23 Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen Unknown status NCT01560572 Phase 4
24 Morbidity and Mortality Among Dialysis Patients After Treatment for Depression Unknown status NCT00442429 Phase 4
25 Multi-center Clinical Study of Early Antibios of Severe Acute Pancreatitis Unknown status NCT01992198 Phase 4
26 Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function Unknown status NCT00541814 Phase 4
27 Clinical Impact of Bacteriuria on Chronic Inflammation in Asymptomatic Hemodialysis Patients Unknown status NCT01570556 Phase 4
28 Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients Unknown status NCT02036554 Phase 4
29 Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb)/Tacrolimus/Mycophenolate in Kidney Transplantation Unknown status NCT00246129 Phase 4
30 Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal Unknown status NCT00896012 Phase 4
31 Fibrosis in Renal Allografts Unknown status NCT00493194 Phase 4
32 A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids Unknown status NCT00693446 Phase 4
33 The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females Unknown status NCT02094703 Phase 4
34 Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC Unknown status NCT01795794 Phase 4
35 Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate Unknown status NCT00480376 Phase 4
36 The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis Unknown status NCT02105519 Phase 4
37 Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome Unknown status NCT01346007 Phase 4
38 Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients Unknown status NCT00772824 Phase 4
39 A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) Unknown status NCT01731301 Phase 4
40 Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda Unknown status NCT00674921 Phase 4
41 Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion Unknown status NCT01353105 Phase 4
42 Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney Injury Unknown status NCT00837057 Phase 4
43 Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts Unknown status NCT01928407 Phase 4
44 Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis Unknown status NCT00871104 Phase 4
45 Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy Unknown status NCT01537055 Phase 4
46 Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation Unknown status NCT00986713 Phase 4
47 Pharmacokinetic of Ceftriaxone in Septic ICU Patients Unknown status NCT00449800 Phase 4
48 Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria Unknown status NCT01636895 Phase 4
49 Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects Unknown status NCT02404233 Phase 4
50 Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion Unknown status NCT00313066 Phase 4

Search NIH Clinical Center for Renal Infectious Disease

Genetic Tests for Renal Infectious Disease

Anatomical Context for Renal Infectious Disease

Publications for Renal Infectious Disease

Variations for Renal Infectious Disease

Expression for Renal Infectious Disease

Search GEO for disease gene expression data for Renal Infectious Disease.

Pathways for Renal Infectious Disease

GO Terms for Renal Infectious Disease

Sources for Renal Infectious Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....